Scopus
YÖKSİS Eşleşti
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · Nisan 2021
YÖKSİS Kayıtları
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ABDULLAH SİVRİKAYA →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR SEDAT ABUŞOĞLU →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ABDULLAH SİVRİKAYA →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR FATMA HÜMEYRA YERLİKAYA AYDEMİR →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ŞEREFNUR ÖZTÜRK →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ALİ ÜNLÜ →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ALİ ÜNLÜ →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR ALİ ÜNLÜ →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
PROFESÖR FATMA HÜMEYRA YERLİKAYA AYDEMİR →
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis
Journal of Neuroimmunology · 2021 SCI-Expanded
DOÇENT GÜLSÜM ABUŞOĞLU →
Makale Bilgileri
DergiJournal of Neuroimmunology
Yayın TarihiNisan 2021
Cilt / Sayfa353
Scopus ID2-s2.0-85100413325
Özet
Multiple sclerosis (MS) is an autoinflammatory, chronic central nervous system disease. In the pathogenesis of the disease increased nitric oxide (NO) levels play an important role. Nitric oxide (NO) has neuroprotective effects in physiological conditions, however, it is thought that excessive NO formation in MS may lead to demyelination and axonal damage. Derivatives of methylarginine including asymmetric dimethyl arginine (ADMA), L-N monomethyl arginine (L-NMMA), symmetric dimethyl arginine (SDMA) directly or indirectly reduce NO production. Our aim was to measure the levels of methylarginine derivatives and citrulline, ornithine, arginine, homoarginine levels, which are metabolites associated with NO metabolism, in MS subgroups.
Yazarlar (9)
1
Duygu Eryavuz Onmaz
ORCID: 0000-0001-8564-1824
2
Saziye Melike Turan Isık
3
Sedat Abusoglu
ORCID: 0000-0002-2984-0527
4
Ahmet Hakan Ekmekci
5
Abdullah Sivrikaya
6
Gulsum Abusoglu
7
Şerefnur Öztürk
8
Humeyra Yerlikaya Aydemir
9
Ali Ünlü
ORCID: 0000-0002-9991-3939
Anahtar Kelimeler
iNOS
Methylated arginine load
Multiple sclerosis
Nitric oxide
Kurumlar
Selçuk Tip Fakültesi
Konya Turkey
Selçuk Üniversitesi
Selçuklu Turkey